Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report

Identifieur interne : 003B39 ( Main/Exploration ); précédent : 003B38; suivant : 003B40

SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report

Auteurs : Alastair Wilkins [Royaume-Uni] ; Jerry M. Brown [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]

Source :

RBID : ISTEX:60163DD9E3887A992F60E772EFEFFCCE890DA0E7

Descripteurs français

English descriptors

Abstract

We report on a young woman from the United Kingdom with L‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society

Url:
DOI: 10.1002/mds.10715


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report</title>
<author>
<name sortKey="Wilkins, Alastair" sort="Wilkins, Alastair" uniqKey="Wilkins A" first="Alastair" last="Wilkins">Alastair Wilkins</name>
</author>
<author>
<name sortKey="Brown, Jerry M" sort="Brown, Jerry M" uniqKey="Brown J" first="Jerry M." last="Brown">Jerry M. Brown</name>
</author>
<author>
<name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:60163DD9E3887A992F60E772EFEFFCCE890DA0E7</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.10715</idno>
<idno type="url">https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C49</idno>
<idno type="wicri:Area/Istex/Curation">001C49</idno>
<idno type="wicri:Area/Istex/Checkpoint">002520</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Wilkins A:sca:presenting:as</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15133829</idno>
<idno type="wicri:Area/PubMed/Corpus">003458</idno>
<idno type="wicri:Area/PubMed/Curation">003458</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003315</idno>
<idno type="wicri:Area/Ncbi/Merge">000E26</idno>
<idno type="wicri:Area/Ncbi/Curation">000E26</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E26</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Wilkins A:sca:presenting:as</idno>
<idno type="wicri:Area/Main/Merge">005497</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0302587</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002183</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000B38</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002009</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Wilkins A:sca:presenting:as</idno>
<idno type="wicri:Area/Main/Merge">005847</idno>
<idno type="wicri:Area/Main/Curation">003B39</idno>
<idno type="wicri:Area/Main/Exploration">003B39</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report</title>
<author>
<name sortKey="Wilkins, Alastair" sort="Wilkins, Alastair" uniqKey="Wilkins A" first="Alastair" last="Wilkins">Alastair Wilkins</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Addenbrooke's Hospital, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Brown, Jerry M" sort="Brown, Jerry M" uniqKey="Brown J" first="Jerry M." last="Brown">Jerry M. Brown</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Addenbrooke's Hospital, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Addenbrooke's Hospital, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-05">2004-05</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="593">593</biblScope>
<biblScope unit="page" to="595">595</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">60163DD9E3887A992F60E772EFEFFCCE890DA0E7</idno>
<idno type="DOI">10.1002/mds.10715</idno>
<idno type="ArticleID">MDS10715</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Alleles</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Case study</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (therapeutic use)</term>
<term>Nerve Tissue Proteins</term>
<term>Nervous system diseases</term>
<term>Parkinsonian Disorders (diagnosis)</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonian Disorders (genetics)</term>
<term>Parkinsonism</term>
<term>Phenotype</term>
<term>Proteins (genetics)</term>
<term>SCA2</term>
<term>Spinocerebellar Ataxias (diagnosis)</term>
<term>Spinocerebellar Ataxias (genetics)</term>
<term>Trinucleotide Repeat Expansion (genetics)</term>
<term>United Kingdom</term>
<term>levodopa</term>
<term>parkinsonism</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Parkinsonian Disorders</term>
<term>Spinocerebellar Ataxias</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Parkinsonian Disorders</term>
<term>Spinocerebellar Ataxias</term>
<term>Trinucleotide Repeat Expansion</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Alleles</term>
<term>Female</term>
<term>Humans</term>
<term>Nerve Tissue Proteins</term>
<term>Phenotype</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Etude cas</term>
<term>Homme</term>
<term>Lévodopa</term>
<term>Parkinsonisme</term>
<term>Royaume Uni</term>
<term>Système nerveux pathologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We report on a young woman from the United Kingdom with L‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Wilkins, Alastair" sort="Wilkins, Alastair" uniqKey="Wilkins A" first="Alastair" last="Wilkins">Alastair Wilkins</name>
</noRegion>
<name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
<name sortKey="Brown, Jerry M" sort="Brown, Jerry M" uniqKey="Brown J" first="Jerry M." last="Brown">Jerry M. Brown</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B39 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B39 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:60163DD9E3887A992F60E772EFEFFCCE890DA0E7
   |texte=   SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024